A meta-analysis of Watson for Oncology in clinical application
WEBMar 11, 2021 · Watson for Oncology (WFO), an artificial intelligence assistant decision system, was developed by IBM Corporation (USA) with the help of top oncologists from Memorial Sloan Kettering Cancer...
IBM Watson for Oncology - Apollo Hospitals
WEBApollo Hospitals in partnership with IBM Watson Health is now offering AI-enabled Watson for Oncology. Watson for Oncology helps your oncologist personalize your treatment plan based on expertise from leading U.S. oncologists.
Using Artificial Intelligence (Watson for Oncology) for Treatment ...
WEBSep 25, 2018 · The clinical decision support system Watson for Oncology (WFO) is an outstanding representative AI in the medical field, and it can provide to cancer patients prompt treatment recommendations comparable with ones made by expert oncologists.
How IBM Watson Overpromised and Underdelivered on AI Health …
WEBApr 2, 2019 · MD Anderson Cancer Center partnered with IBM Watson to create an advisory tool for oncologists. The tool used natural-language processing (NLP) to summarize patients’ electronic health records, then searched databases to provide treatment recommendations.
Watson for Oncology and breast cancer treatment ... - Annals of Oncology
WEBThis observational study compared treatment recommendations for 638 breast cancer cases between an artificial intelligence system (Watson for Oncology) and a tumor board. The system carried out well with overall concordance in excess of 90% but varying by patient age and tumor stage.
Watson for Oncology and breast cancer treatment ... - IBM …
WEBWe report here the results of examining the level of agreement (concordance) between treatment recommendations made by the AI CDSS Watson for Oncology (WFO) and a multidisciplinary tumor board for breast cancer.
Memorial Sloan Kettering Cancer Center, IBM to Collaborate in …
WEBMar 22, 2012 · Memorial Sloan Kettering and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson to provide medical professionals with improved access to comprehensive cancer data and practices.
IBM pitched Watson as a revolution in cancer care. It's nowhere …
WEBSep 5, 2017 · IBM executives acknowledged Watson for Oncology, which has been in development for nearly six years, is in its infancy. But they said it is improving rapidly, noting that by year’s end, the...
“A Tool, Not a Crutch”: Patient Perspectives About IBM Watson …
WEBJan 28, 2019 · INTRODUCTION. IBM Watson for Oncology trained by Memorial Sloan Kettering (WFO; MSK) is a clinical decision support tool developed in collaboration between IBM and MSK to harness the power of cognitive technology to provide clinicians with informed treatment recommendations for patients with cancer. 1 WFO has been trained by MSK clinicians ...
Confronting the Criticisms Facing Watson for Oncology
WEBSep 10, 2019 · Over the past 2 years, IBM’s Watson for Oncology cognitive computing system, which uses artificial intelligence (AI) algorithms to generate treatment recommendations, has come under fire for allegedly not delivering on expectations to provide state-of-the-art personalized treatment for patients with cancer and for producing advice that is ...
Skip to content